• 213
  • 16
  • Favorite

Singapore Stocks To Watch: Keppel, Keppel Infra Trust, ISDN

Tiger Newspress2022-07-13

THE following companies saw new developments that may affect trading of their securities on Wednesday (Jul 13):

KeppelKeppel Infrastructure Trust: Keppel Corporation And Keppel Infrastructure Trust To Jointly Invest In European Onshore Wind Energy Portfolio. Fundco Will Initially Co-Invest In 49% Of Three Operating Wind Farms In Sweden And Norway. Keppel Corp, Keppel Infrastructure Fund Management Committing Eur 160 Million For 33.3% Stake In Joint Investment Vehicle.Foras Will Hold Remaining 51% Stake In Projects.

Proposed Co-Investment In Initial Portfolio Is Expected To Be Completed By 3Q2022.Purchase Consideration For 49% Of Initial Portfolio Is Approximately Eur 176 Million.Transaction Is Expected To Support Kit'S Overall Distributable Income Per Unit Accretion. Fundco Will Further Have A 5-Year Exclusive Right And Obligation To Co-Invest In 49% Of All Foras' Eligible Pipeline.

ISDN: ISDN Holdings will withdraw the scrip dividend scheme for FY2021 and distribute the proposed dividend of S$0.0145 fully in cash instead, given that the issue price of the scrip dividend is lower than the counter’s market price.

The engineering company, in its statement filed after the market close on Tuesday (Jul 12), said that the issue price of each new share under the scrip dividend scheme is S$0.501, an amount that should not be set at more than 10 per cent discount or exceed the average of the last prices on each of the 5 trading days prior to and ending on the record date of Jul 7.

However, its last trading price for each of the 5 trading days to Jul 7 averaged only S$0.467 — lower than the issue price of the scrip dividend.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment16

  • Taetaena
    ·2022-10-05
    Ok
    Reply
    Report
  • MrHuattt
    ·2022-08-05
    Isdn
    Reply
    Report
  • haircut
    ·2022-07-13
    Market softened 
    Reply
    Report
  • Newnew
    ·2022-07-13
    Thank 
    Reply
    Report
  • Sigit waloyo
    ·2022-07-13
    Ok
    Reply
    Report
    Fold Replies
  • hphoa
    ·2022-07-13
    Ok
    Reply
    Report
  • VivianChua
    ·2022-07-13
    Ok 
    Reply
    Report
    Fold Replies
    • Helloyah
      ok
      2022-07-13
      Reply
      Report
  • SvdB
    ·2022-07-13
    Ok
    Reply
    Report
  • JesseC
    ·2022-07-13
    Nice
    Reply
    Report
    Fold Replies
    • JesseC
      Ok
      2022-07-13
      Reply
      Report
  • WindyMoon
    ·2022-07-13
    [Cool] 
    Reply
    Report
    Fold Replies
  • AlfonsoDex
    ·2022-07-13
    Ok
    Reply
    Report
  • xiaobaii
    ·2022-07-13
    like & comment please 
    Reply
    Report
    Fold Replies
    • Ivanyzs
      K
      2022-07-13
      Reply
      Report
  • TheEndIsNear
    ·2022-07-13
    Still watching.
    Reply
    Report
  • SirBahamut
    ·2022-07-13
    Hmmm KIT... mixed infra
    Reply
    Report
  • Jazim
    ·2022-07-13
    Okay 
    Reply
    Report
    Fold Replies
    • ACECHUA
      LIke
      2022-07-13
      Reply
      Report
    • xiaobaii
      like & comment please
      2022-07-13
      Reply
      Report
  • ParrySKLow
    ·2022-07-13
    Thanks
    Reply
    Report
    Fold Replies
errorbox banner

抱歉,当前请求异常(-1)

7x24

  • 16:22

    Qiagen Nv - Raises Full-Year 2025 Adjusted Diluted EPS Outlook to $2.35 Cer

  • 16:22

    Qiagen Nv - Q1 2025 Net Sales Grew Approximately 5% to $483 Million

  • 16:22

    Eqs-Adhoc: Qiagen N.v.: Qiagen Announces Strong Preliminary Q1 2025 Results and Updates Full-Year 2025 Adjusted Earnings per Share Outlook

  • 16:22

    Qiagen Q1 Adjusted EPS USD 0.55

  • 16:00

    Rhythm Pharmaceuticals to Announce Topline Results From Pivotal Phase 3 Transcend Trial Evaluating Setmelanotide in Patients With Acquired Hypothalamic Obesity

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial